Botanic Healthcare Reported Positive Ironnox Clinical Trial

A new clinical trial suggests Ironnox improves iron levels in women while reducing common side effects.

Updated on Oct. 2, 2026 in Nutrition

Bold flat-color editorial illustration of a laboratory beaker and a floating leaf, representing medical clinical trial results.
Botanic Healthcare's Ironnox supplement showed improved iron levels and fewer side effects than standard ferric pyrophosphate in a recent randomized clinical trial. AI Illustration. Upload story photo >

Live Poll

Should medical treatments prioritize reducing side effects even if it increases the complexity of delivery?

Botanic Healthcare has released results from a randomized clinical trial showing that its Ironnox ingredient significantly improves iron levels in women with iron-deficiency anemia. The findings highlight higher efficacy and improved tolerability compared to standard ferric pyrophosphate supplements.

Why it matters

Standard oral iron supplements frequently cause significant gastrointestinal distress and inflammation in users. This development offers a potential alternative that may improve patient compliance and health outcomes for those suffering from anemia.

In a 56-day study of 60 women, participants using Ironnox showed 18.8% higher transferrin saturation and an 18% lower fatigue score compared to those taking ferric pyrophosphate.

The players

Botanic Healthcare

Botanic Healthcare is a manufacturer that specializes in the production of herbal extracts and nutritional ingredients.

The details

The study utilized liposomal delivery technology to compare Ironnox against standard ferric pyrophosphate. While 20% of participants in the control group reported gastrointestinal side effects, zero participants in the Ironnox group experienced such issues.

Timeline

  1. The clinical trial lasted for a total of 56 days.

The Big Picture

This study follows the ongoing trend of applying liposomal delivery technology to improve the efficacy and absorption rates of mineral supplements. The clinical evaluation of liposomal delivery technology provides a framework for analyzing how Ironnox attempts to solve the bioavailability challenges of traditional iron supplementation.

Patients struggling with iron deficiency may find this alternative more tolerable, potentially reducing the gastrointestinal side effects associated with traditional iron therapy. Readers should consult with a healthcare provider before making changes to their existing supplement regimen.

The takeaway

Advancements in delivery technology are increasingly being used to mitigate the adverse side effects of essential mineral supplementation. Patients should monitor their physical response to any new supplement and discuss efficacy metrics with their doctor.

Further reading

For more information on current dietary research, visit the Nutrition section.

Source note: This article includes information reported by Nutritioninsight.

Live Poll

Should medical treatments prioritize reducing side effects even if it increases the complexity of delivery?